31 Jan 2025
Clinical Trials with Re:Cognition Health
Dr Emer MacSweeney, CEO and Founder of Re:Cognition Health talks about the new medications available for Alzheimer's disease. We hear the stories of two clinical trial participants, Mike and David, and clinical trial partner, Cheryl, and how participating on a clinical trial for these new medications has helped them.
){kind=logo}
)
)
)
)
){kind=logo}
){kind=logo}
)